The global market for GLP-1 receptor agonists shows a surge in demand due to their proven results in managing type 2 diabetes. Several pharmaceutical companies have secured FDA approval to manufacture these life-changing medications. {Novo Nordisk|Ascensia Pharmaremains a leading developer of GLP-1 receptor agonists, with highly regarded produc